P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.
Brain wave measurements offer a non-invasive way to detect early cognitive decline across multiple neurological disorders, though standardized protocols remain needed.
This systematic review supports the utility of P300 ERP as a broadly applicable, non-invasive cognitive biomarker across neurological and neuropsychiatric disorders, particularly for early cognitive decline detection. Key barriers to clinical adoption remain standardization of recording protocols and lack of disorder-specific cutoffs.
What the study was
- Study design
- Systematic review
- Population
- Patients with neurological and neuropsychiatric disorders; systematic review of P300 ERP studies
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Revista de Neurología
Why it surfaced
Systematic review on P300 as cognitive biomarker; relevant for aging/cognitive decline detection watchlist area but in a lower-tier journal (Rev Neurol); classification_confidence medium as only abstract reviewed.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.